Trandolapril
9 NDCs across 3 manufacturers|9 Generic,0 Brand
Trandolapril is used to treat diabetic nephropathies, heart failure, hypertension and left ventricular dysfunction, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 26, 1996, and the first generic was approved Dec 12, 2006. FDA's Orange Book lists 9 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $1 million on Trandolapril across 59,000 claims for 14,000 beneficiaries.
Trandolapril is available as 9 NDCs from 3 manufacturers (9 generic, 0 brand), with NADAC prices from $0.16 to $0.29 per EA — a 85% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
9
9G / 0B
Manufacturers
3
competing in market
Price Spread
$0.16 – $0.29
per EA
7d Activity
avg -1.3% WoW · of 9 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Aurobindo Pharma Limited manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Angiotensin Converting Enzyme Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing TRANDOLAPRIL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TRANDOLAPRIL 1 MG TABLET | $0.2882 per EA | — |
TRANDOLAPRIL 4 MG TABLET | $0.2521 per EA | — |
TRANDOLAPRIL 2 MG TABLET | $0.2244 per EA | — |
TRANDOLAPRIL 2 MG TABLET | $0.1622 per EA | -11.09% |
TRANDOLAPRIL 2 MG TABLET | $0.1622 per EA | -11.09% |
TRANDOLAPRIL 1 MG TABLET | $0.1572 per EA | +5.17% |
TRANDOLAPRIL 1 MG TABLET | $0.1572 per EA | +5.17% |
TRANDOLAPRIL 4 MG TABLET | $0.1561 per EA | +1.99% |
TRANDOLAPRIL 4 MG TABLET | $0.1561 per EA | +1.99% |
Frequently Asked Questions
What is Trandolapril used to treat?
Trandolapril is used to treat diabetic nephropathies, heart failure, hypertension and left ventricular dysfunction, per the National Library of Medicine's MED-RT classification.
When did Trandolapril become available as a generic?
FDA approved the first generic Trandolapril (ANDA) on Dec 12, 2006. The Orange Book currently lists 9 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Trandolapril?
In 2024, Medicare Part D spent $1 million on Trandolapril across 59,000 claims for 14,000 beneficiaries.
How many Trandolapril products are on the market?
The Trandolapril drug market contains 9 NDCs from 3 manufacturers — 9 generic and 0 brand products.
What is the price range for Trandolapril?
NADAC reference prices for Trandolapril range from $0.1561 to $0.2882 per EA — a 85% difference between cheapest and most expensive.
Which manufacturers make Trandolapril?
3 manufacturers list Trandolapril in NADAC. Ranked by number of NDCs, the largest are Aurobindo Pharma Limited (3), Lupin Pharmaceuticals Inc. (3), Rising Pharma Holdings Inc. (3).
How has the price of Trandolapril changed recently?
Over the past 7 days, 4 Trandolapril NDCs rose and 2 fell, with a market-wide average change of -1.3%.